Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
2 studies found for:    16226705 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Recruiting Application of Two Anti-angiogenesis Drugs Combined With Chemotherapy in Advanced Colorectal Cancer Under the Background of Precision Medical
Condition: Colorectal Neoplasms
Interventions: Drug: Two Anti-angiogenesis Drugs(Endostar and Thalidomide);   Drug: Pure chemotherapy(Xelox)
2 Active, not recruiting 1st-line Activity of Dovitinib and Correlation With Genetic Changes in RCC
Condition: Clear Cell Renal Cell Carcinoma
Intervention: Drug: Dovitinib

Indicates status has not been verified in more than two years